Horizon Discovery is a world-leader in the application of gene editing and is at the centre of innovation and drug discovery.

 

Background

  • High science story with ongoing requirement for education of stakeholders

 

Our strategy

  • Work in partnership with management to develop an international IR and profile raising strategy to build knowledge and awareness
  • Simplify the story, outline achievable milestones and make the news impactful
  • Target international media to profile the Horizon investment case as the Company delivers on strategy and transitions to EBITDA positive in 2017

23,000+

catalogue products and related research services in over 50 countries

 

Outcome

  • Clearer announcements and media coverage, including tips by the Sunday Times’ Business Editor and the Financial Times, have had a positive impact on the share price with clear and well understood messages